| ACE | angiotensin-converting enzyme |
| ACEI | angiotensin converting enzyme inhibitors |
| ADMA | asymmetric dimethylarginine |
| APC | antigen-presenting cell |
| AT1R | angiotensin type 1 receptor |
| AT2R | angiotensin type 2 receptor |
| BH4 | tetrahydrobiopterin |
| BR1 | bradykinin receptor type 1 |
| CCR5 | receptor for RANTES |
| CRP | C-reactive protein |
| eNOS | endothelial nitric oxide synthase |
| ET1 | endothelin 1 |
| HMWK | high-molecular-weight kininogen |
| IL-17 | interleukin 17 |
| MCT sets | Maximal Common Transition sets |
| MPS | mononuclear phagocyte system |
| MSS | Mean Split Silhouette |
| NO | nitric oxide |
| PGE2 | prostaglandin |
| PGI2 | prostacyclin |
| RANTES | regulated on activation, normal T-cell expressed and secreted |
| RAS, RAA | renin-angiotensin system |
| ROS | reactive oxygen species |
| TNF alpha | tumor necrosis factor alpha |
| TonEBP | tonicity enhancer binding protein |
| UPGMA | Unweighted Pair Group Method with Arithmetic Mean |
| VEGF-C | vascular endothelial growth factor C |
| VEGFR2 | vascular endothelial growth factor receptor 2 |
| VEGFR3 | vascular endothelial growth factor receptor 3 |